Insulin-like action of ouabain. II. Primary antilipolytic effect through inhibition of adenyl cyclase.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000273:Adipose Tissue / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002247:Carbon Isotopes; D004822:Epididymis / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors*; D007328:Insulin; D050356:Lipid Metabolism; D008297:Male; D009829:Oleic Acids / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology*; D010169:Palmitic Acids / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D051381:Rats
D000227:Adenine Nucleotides; D002247:Carbon Isotopes; D007328:Insulin; D009829:Oleic Acids; D010169:Palmitic Acids; D002110:Caffeine; D010042:Ouabain; D000324:Adrenocorticotropic Hormone; D005964:Glucosyltransferases; D005947:Glucose; D011188:Potassium